160 related articles for article (PubMed ID: 33202285)
1. Lactobacillus reuteri DSM 17938 alleviates d-galactosamine-induced liver failure in rats.
Jiang H; Yan R; Wang K; Wang Q; Chen X; Chen L; Li L; Lv L
Biomed Pharmacother; 2021 Jan; 133():111000. PubMed ID: 33202285
[TBL] [Abstract][Full Text] [Related]
2. Lactobacillus helveticus R0052 alleviates liver injury by modulating gut microbiome and metabolome in D-galactosamine-treated rats.
Wang Q; Lv L; Jiang H; Wang K; Yan R; Li Y; Ye J; Wu J; Wang Q; Bian X; Yang L; Jiang X; Xie J; Lu Y; Shen J; Li L
Appl Microbiol Biotechnol; 2019 Dec; 103(23-24):9673-9686. PubMed ID: 31713675
[TBL] [Abstract][Full Text] [Related]
3.
Lv L; Yao C; Yan R; Jiang H; Wang Q; Wang K; Ren S; Jiang S; Xia J; Li S; Yu Y
mSystems; 2021 Jun; 6(3):e0038421. PubMed ID: 34128694
[TBL] [Abstract][Full Text] [Related]
4. Bifidobacterium adolescentis CGMCC 15058 alleviates liver injury, enhances the intestinal barrier and modifies the gut microbiota in D-galactosamine-treated rats.
Li Y; Lv L; Ye J; Fang D; Shi D; Wu W; Wang Q; Wu J; Yang L; Bian X; Jiang X; Jiang H; Yan R; Peng C; Li L
Appl Microbiol Biotechnol; 2019 Jan; 103(1):375-393. PubMed ID: 30345482
[TBL] [Abstract][Full Text] [Related]
5. Bifidobacterium longum R0175 Protects Rats against d-Galactosamine-Induced Acute Liver Failure.
Wang K; Lv L; Yan R; Wang Q; Jiang H; Wu W; Li Y; Ye J; Wu J; Yang L; Bian X; Jiang X; Lu Y; Xie J; Wang Q; Shen J; Li L
mSphere; 2020 Jan; 5(1):. PubMed ID: 31996423
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of the Immunomodulatory Effect of the Combination of Live
Lv L; Mu D; Du Y; Yan R; Jiang H
Front Immunol; 2021; 12():694344. PubMed ID: 34211480
[TBL] [Abstract][Full Text] [Related]
7. Administration of Lactobacillus salivarius LI01 or Pediococcus pentosaceus LI05 improves acute liver injury induced by D-galactosamine in rats.
Lv LX; Hu XJ; Qian GR; Zhang H; Lu HF; Zheng BW; Jiang L; Li LJ
Appl Microbiol Biotechnol; 2014 Jun; 98(12):5619-32. PubMed ID: 24639205
[TBL] [Abstract][Full Text] [Related]
8. The synergy of dietary supplements
Zhuge A; Li S; Yuan Y; Li B; Li L
Food Funct; 2021 Oct; 12(20):10239-10252. PubMed ID: 34546256
[No Abstract] [Full Text] [Related]
9. Lactobacillus reuteri improves function of the intestinal barrier in rats with acute liver failure through Nrf-2/HO-1 pathway.
Zhou Q; Wu F; Chen S; Cen P; Yang Q; Guan J; Cen L; Zhang T; Zhu H; Chen Z
Nutrition; 2022; 99-100():111673. PubMed ID: 35567844
[TBL] [Abstract][Full Text] [Related]
10. Probiotic Lactobacillus casei Shirota prevents acute liver injury by reshaping the gut microbiota to alleviate excessive inflammation and metabolic disorders.
Yan R; Wang K; Wang Q; Jiang H; Lu Y; Chen X; Zhang H; Su X; Du Y; Chen L; Li L; Lv L
Microb Biotechnol; 2022 Jan; 15(1):247-261. PubMed ID: 33492728
[TBL] [Abstract][Full Text] [Related]
11. Early intervention with probiotics and metformin alleviates liver injury in NAFLD rats via targeting gut microbiota dysbiosis and p-AKT/mTOR/LC-3II pathways.
Seif El-Din SH; Salem MB; El-Lakkany NM; Hammam OA; Nasr SM; Okasha H; Ahmed LA; Saleh S; Botros SS
Hum Exp Toxicol; 2021 Sep; 40(9):1496-1509. PubMed ID: 33678036
[TBL] [Abstract][Full Text] [Related]
12. Bifidobacterium pseudocatenulatum LI09 and Bifidobacterium catenulatum LI10 attenuate D-galactosamine-induced liver injury by modifying the gut microbiota.
Fang D; Shi D; Lv L; Gu S; Wu W; Chen Y; Guo J; Li A; Hu X; Guo F; Ye J; Li Y; Li L
Sci Rep; 2017 Aug; 7(1):8770. PubMed ID: 28821814
[TBL] [Abstract][Full Text] [Related]
13. Human-derived probiotic Lactobacillus reuteri strains differentially reduce intestinal inflammation.
Liu Y; Fatheree NY; Mangalat N; Rhoads JM
Am J Physiol Gastrointest Liver Physiol; 2010 Nov; 299(5):G1087-96. PubMed ID: 20798357
[TBL] [Abstract][Full Text] [Related]
14. Effect of Lactobacillus supplementation with and without arginine on liver damage and bacterial translocation in an acute liver injury model in the rat.
Adawi D; Kasravi FB; Molin G; Jeppsson B
Hepatology; 1997 Mar; 25(3):642-7. PubMed ID: 9049212
[TBL] [Abstract][Full Text] [Related]
15. Probiotic Lactobacillus casei Zhang reduces pro-inflammatory cytokine production and hepatic inflammation in a rat model of acute liver failure.
Wang Y; Xie J; Li Y; Dong S; Liu H; Chen J; Wang Y; Zhao S; Zhang Y; Zhang H
Eur J Nutr; 2016 Mar; 55(2):821-831. PubMed ID: 25893720
[TBL] [Abstract][Full Text] [Related]
16. Multidisciplinary and Comparative Investigations of Potential Psychobiotic Effects of
Beck BR; Park GS; Jeong DY; Lee YH; Im S; Song WH; Kang J
Front Cell Infect Microbiol; 2019; 9():269. PubMed ID: 31404163
[TBL] [Abstract][Full Text] [Related]
17.
Liu T; Zhou L; Li X; Song W; Liu Y; Wu S; Wang P; Dai X; Shi L
J Agric Food Chem; 2024 May; 72(17):9880-9892. PubMed ID: 38646869
[No Abstract] [Full Text] [Related]
18. Lactobacillus salivarius LI01 encapsulated in alginate-pectin microgels ameliorates D-galactosamine-induced acute liver injury in rats.
Zhuge A; Li B; Yuan Y; Lv L; Li Y; Wu J; Yang L; Bian X; Wang K; Wang Q; Yan R; Zhu X; Li L
Appl Microbiol Biotechnol; 2020 Sep; 104(17):7437-7455. PubMed ID: 32666187
[TBL] [Abstract][Full Text] [Related]
19.
Liu Y; Tian X; He B; Hoang TK; Taylor CM; Blanchard E; Freeborn J; Park S; Luo M; Couturier J; Tran DQ; Roos S; Wu G; Rhoads JM
Am J Physiol Gastrointest Liver Physiol; 2019 Dec; 317(6):G824-G838. PubMed ID: 31482733
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment of lipopolysaccharide (LPS) ameliorates D-GalN/LPS induced acute liver failure through TLR4 signaling pathway.
Zhang S; Yang N; Ni S; Li W; Xu L; Dong P; Lu M
Int J Clin Exp Pathol; 2014; 7(10):6626-34. PubMed ID: 25400741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
